MediciNova Analyst Price Targets

Wall Street analyst price targets and consensus rating for MediciNova (MNOV).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$7Upside to Avg. PT+418.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	Roth Capital	Boobalan Pachaiyappan	Initiate	Buy	$6
May 4, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Mar 23, 2026	Maxim Group	Jason McCarthy	Reinstates	Buy	$6
Mar 16, 2026	HC Wainwright & Co.	Lander Egaña Gorroño	Initiate	Buy	$10
Jan 30, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Dec 18, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Dec 8, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Nov 4, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Oct 31, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Sep 22, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Aug 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Jul 24, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Jun 16, 2025	B. Riley Securities	Mayank Mamtani	PT Cut	Buy	$6→$5
Apr 9, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Mar 14, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Feb 21, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Dec 6, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$9
Dec 2, 2024	D. Boral Capital	Jason Kolbert	Initiate	Buy	$9

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN rated Market Perform at $25.

Avi Kapoor

PRO
Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $6.

Benzinga Newsdesk

This Qualcomm Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts changed outlook for top names like SUNB, SLDP, ZVRA, COHU, and MNOV. See analyst ratings page for more info. Consider buying COHU stock.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

HC Wainwright & Co. analyst Lander Egaña Gorroño initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $10.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.

Benzinga Newsdesk

MediciNova Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

MediciNova Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

This Qualcomm Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

PRO
D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

People Also Watch

People Also Watch

MediciNova Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

MediciNova Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRORoth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

This Qualcomm Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROHC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

PROD. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

People Also Watch

People Also Watch

PRO
Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

PRO
HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

PRO
D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target